English
Home > Products > CAS:57-83-0

China CAS:57-83-0 Manufacturer

We are commitment to offer the competitive price ,outstanding products quality, as well as fast delivery for CAS:57-83-0, With our rules of " small business track record, partner trust and mutual benefit", welcome all of you to definitely work together , expand with each other.
CAS:57-83-0, Our aim is to help customers realize their goals. We have been making great efforts to achieve this win-win situation and sincerely welcome you to join us. In a word, when you choose us, you choose a perfect life. Welcome to visit our factory and welcome your order! For further inquiries, remember to do not hesitate to contact us.

Related Products

Hot Products

  • Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride has USP specification. DMF approved.

    CAS:175865-59-5

  • Triacetyl-ganciclovir

    Triacetyl-ganciclovir

    Triacetyl-ganciclovir is a Ganciclovir derivative.

    CAS:86357-14-4

  • Mono-acetyl Ganciclovir

    Mono-acetyl Ganciclovir

    Mono-acetyl Ganciclovir Specification: Min 97.0%

    CAS:88110-89-8

  • Mifepristone Capsules

    Mifepristone Capsules

    Mifepristone Capsules Specifications：10mg*1
    Indications：Emergency Contraceptive
  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide

    N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide

    N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide is an intermediate of Dutasteride.

    CAS:98319-24-5

  • Related Blog
  • Reviews

  • 2021 API Exhibition Wuhan

    October 2021
    API China is a well-established comprehensive pharmaceuticals and chemicals show in Chinese pharmaceutical industry. With more than 40 years’ experience in China, it has been a well-known celebration for all parties involved in Chinese Pharmaceutical market.

  • Budesonide: A Great Product in the Treatment of Respiratory Ailments

    Please feel free to reach out to us for more information on product details.

  • Welcome to CPHI Middle East 2024

    CPHI Middle East 2024 will be held in Riyadh from 10 Dec 2024 - 12 Dec 2024. The pavilion is located at Riyadh Front Exhibition & Convention Center Riyadh and our booth number is 3.G43.

  • What are the categories of pharmaceutical intermediates?

    Pharmaceutical intermediates are classified by therapeutic areas, chemical structures, synthesis stages and production technologies, covering multiple types such as anti-tumor and anti-infection. They are key precursors in the synthesis of active pharmaceutical ingredients.

  • Are There Any Side Effects or Risks Associated with Levonorgestrel Capsules

    As a leading provider in women's reproductive health, we at Humanwell often receive questions from individuals considering emergency contraception. One of the most frequent and important queries we encounter is about the safety profile of Levonorgestrel Capsules.

  • What Is Dutasteride and How Does It Work to Treat Hair Loss and BPH

    Dutasteride is a powerful 5α-reductase inhibitor widely used in the treatment of benign prostatic hyperplasia (BPH) and increasingly discussed for male pattern hair loss. This article provides a comprehensive overview of what Dutasteride is, how it works at the biochemical level, its benefits, risks, clinical applications, and how it compares with other therapies such as Finasteride.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept